Guangdong Hybribio Biotech: Stock trading has experienced abnormal fluctuations announcement.
Guangdong Hybribio Biotech: Announcement regarding the company and its subsidiaries being granted invention patent authorization.
Guangdong Hybribio Biotech: Announcement of Resolutions from the 20th Meeting of the 5th Board of Directors.
Guangdong Hybribio Biotech: Announcement of Resolutions of the Fifteenth Meeting of the Fifth Session of the Supervisory Board.
Guangdong Hybribio Biotech: Announcement of Resolution of the 14th Meeting of the Fifth Board of Supervisors.
Guangdong Hybribio Biotech: Announcement of the resolution of the 19th meeting of the 5th board of directors.
Guangdong Hybribio Biotech: Announcement Regarding Company and Its Subsidiaries Receiving Notice of Grant of Patent Rights
Guangdong Hybribio Biotech: Announcement Regarding Company and Its Subsidiaries Receiving Notice of Grant of Patent Rights
Guangdong Hybribio Biotech: May 9, 2024 Investor Relations Activity Schedule
Guangdong Hybribio Biotech: Announcement on holding the 2023 online results briefing
Guangdong Hybribio Biotech: Announcement of Resolutions of the 13th Meeting of the Fifth Board of Supervisors
Guangdong Hybribio Biotech: Announcement of Resolutions of the 18th Meeting of the Fifth Board of Directors
Guangdong Hybribio Biotech: Announcement on some changes in accounting policies
Capbio: Investor Relations Activity Record Form for April 24, 2024
Capbio: 2023 Independent Director Debriefing Report (Yang Chunxue)
Capbio: 2023 Annual Audit Report
Capbio: 2023 Supervisory Board Work Report
Capbiotech: Supervisory Board Resolutions Announcement
Capbio: Announcement on renewing the 2024 Audit Institution
Capbio: Board of Directors Special Opinions on the Independent Director Assessment
No Data